Systematic Understanding of Mechanism of Yi-Qi-Huo-Xue Decoction Against Intracerebral Hemorrhagic Stroke Using a Network Pharmacology Approach

Abstract

Background Intracerebral hemorrhage (ICH), a fatal type of stroke, profoundly affects public health. Yi-Qi-Huo-Xue decoction (YQHXD), a traditional Chinese medicine (TCM) prescription, is verified to be an efficient method to treat ICH stroke among the Chinese population. Nevertheless, the pharmacological mechanisms of YQHXD have been unclear. Material/Methods We used a strategy based on network pharmacology to explore the possible multi-component, multi-target, and multi-pathway pattern of YQHXD in treating ICH. First, candidate targets for YQHXD were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Then, these candidate YQHXD targets were used in combination with the known targets for the treatment of ICH stroke to construct the core network (cPPI) using data on protein–protein interaction (PPI). We calculated 5 topological parameters for identification of the main hubs. Pathway enrichment and GO biological process enrichment analyses were performed after the incorporation of the main hubs into ClueGO. Results In total, 55 candidate YQHXD targets for ICH were recognized to be the major hubs in accordance with their topological importance. As suggested by enrichment analysis, the YQHXD targets for ICH were roughly classified into several biological processes (related to redox equilibrium, cell–cell communication, adhesion and collagen biosynthesis, cytokine generation, lymphocyte differentiation and activation, neurocyte apoptosis and development, neuroendocrine system, and vascular development) and related pathways (VEGF, mTOR, NF-kB, RAS/MAPK, JAK/STAT and cytokine–cytokine receptors interaction), indicating those mechanisms underlying the therapeutic effect of YQHXD. Conclusions The present results may serve as a pharmacological framework for TCM studies in the future, helping to promote the use of YQHXD in clinical treatment of ICH.

Mechanism of Fei-Xian Formula in the Treatment of Pulmonary Fibrosis on the Basis of Network Pharmacology Analysis Combined with Molecular Docking Validation

“…e names of 7 herbs were imported into the BATMAN-TCM, Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, and the analysis platform successively, to acquire the chemical compounds with corresponding information [23]. ereafter, the drug likeness (DL) ≥ 0.18 and bioavailability (OB) ≥ 30% were used as the thresholds to screen those possible pharmacodynamic compounds in FXF by the method in literature [24,25]. Additionally, certain compounds that did not conform to the selection thresholds but had great levels in each herb or had wide pharmacological actions, or were utilized to identify single medicine in the pharmacopeia, were incorporated as the possible pharmacodynamic compounds as well, including hirudin, salvianolic acid A, amygdalin, and oroxin [26][27][28][29].…”

Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation

“…Network pharmacology embodies the multi-component, multi-functional, and multi-faceted characteristics of TCM. Recently, people have used it to research TCM [21][22][23]. We predicted the potential mechanism for GRA in GC treatment through network pharmacology, designed experiments to test these predictions, and proposed different directions and ideas for future research.…”